Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.68K Hold
319
﹤0.01% 198
2026
Q1
$8.96K Hold
319
﹤0.01% 171
2025
Q4
$7.94K Hold
319
﹤0.01% 153
2025
Q3
$8.13K Hold
319
﹤0.01% 128
2025
Q2
$7.73K Hold
319
﹤0.01% 135
2025
Q1
$8.08K Hold
319
﹤0.01% 176
2024
Q4
$8.46K Hold
319
﹤0.01% 183
2024
Q3
$9.23K Sell
319
-293
-48% -$8.55K ﹤0.01% 86
2024
Q2
$17.1K Buy
612
+293
+92% +$8.07K 0.01% 103
2024
Q1
$8.85K Hold
319
0.01% 69
2023
Q4
$9.18K Buy
+319
New +$9.64K 0.01% 64

Other funds holding PFE

Fairway Wealth's PFE Position: Q2 2026 in Review

Fairway Wealth held its Pfizer (PFE) position steady in Q2 2026 at 319 shares worth $7.68K. The position accounts for ﹤0.01% of the portfolio, ranked #198.

Fairway Wealth first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $17.1K in Q2 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Fairway Wealth held 319 shares of Pfizer worth $7.68K as of Q2 2026.
  • Fairway Wealth left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of Fairway Wealth's portfolio in Q2 2026, its #198 holding.
  • Fairway Wealth first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Fairway Wealth's Pfizer position peaked at $17.1K in Q2 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Fairway Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.